title: Liraglutide-induced acute pancreatitis.
abstract: An obese lady of 51 year with Type 2 Diabetes Mellitus for 13 years was prescribed Liraglutide, a glucagon like peptide (GLP-1) analogue (Victoza) for glycaemic control and reduction of weight. She was on gliclazide and Insulin prior to initiation of Liraglutide. Eight weeks after initiation of GLP -1 analogue, she developed severe abdominal pain, nausea and vomiting. She was admitted to a private hospital and evaluated. Biochemical tests and CT scan revealed presence of pancreatitis and she was treated for acute pancreatitis. Liraglutide was withdrawn and symptoms subsided. Subsequent follow-up showed that pancreatic enzyme levels were normal.
authors.forename: Santhosh
authors.initials: S
authors.lastname: Jeyaraj
authors.forename: Ananth Samith
authors.initials: AS
authors.lastname: Shetty
authors.forename: Champat Raj Roopesh
authors.initials: CR
authors.lastname: Kumar
authors.forename: Arun
authors.initials: A
authors.lastname: Nanditha
authors.forename: Satheesh
authors.initials: S
authors.lastname: Krishnamoorthy
authors.forename: Arun
authors.initials: A
authors.lastname: Raghavan
authors.forename: K
authors.initials: K
authors.lastname: Raghavan
authors.forename: Ambady
authors.initials: A
authors.lastname: Ramachandran
mesh_terms: D000208:Acute Disease; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D005260:Female; D052216:Glucagon-Like Peptide 1 / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000069450:Liraglutide; D008875:Middle Aged; D010195:Pancreatitis / Q000139:chemically induced*
chemical_list: D007004:Hypoglycemic Agents; D000069450:Liraglutide; D052216:Glucagon-Like Peptide 1